ArticleCancer medicine2025
RETRACTION: Silencing Circular RNA VANGL1 Inhibits Progression of Bladder Cancer by Regulating miR-1184/IGFBP2 Axis.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionD. Yang, H. Qian, Z. Fang, A. Xu, S. Zhao, B. Liu and D. Li, "Silencing Circular RNA VANGL1 Inhibits Progression of Bladder Cancer by Regulating miR-1184/IGFBP2 Axis," Cancer Medicine 9, no. 2 (2020): 700-710, https://doi.org/10.1002/cam4.2650. The above article, published online on 23 November 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stephen Tait; and John Wiley & Sons Ltd. The retraction has been agreed upon due to image overlaps within Figure 2F, as well as between images presented in Figures 2E and 5E. Furthermore, an image from Figure 5F appeared in another article, depicting a different scientific context, and the GAPDH western blot bands in Figure 2B were also identified in a separate publication. Both duplications were found in earlier articles published by different author groups. While the authors cooperated with our investigation and provided some data, they were unable to explain the duplications found in other articles. Due to the nature and extent of these concerns, the editors have lost confidence in the results and conclusions reported in this study. The authors disagree with the retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.